Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone801-568-7000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$64.42 million
Profitability
Miscellaneous
Employees323
Next Earnings Date9/26/2019 (Estimated)
OptionableNot Optionable
Dynatronics (NASDAQ:DYNT) Frequently Asked Questions
What is Dynatronics' stock symbol?
Dynatronics trades on the NASDAQ under the ticker symbol "DYNT."
How were Dynatronics' earnings last quarter?
Dynatronics Co. (NASDAQ:DYNT) released its quarterly earnings data on Wednesday, February, 13th. The medical equipment provider reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.04. The medical equipment provider had revenue of $15.44 million for the quarter, compared to analyst estimates of $16.28 million. Dynatronics had a negative return on equity of 12.65% and a negative net margin of 1.92%. View Dynatronics' Earnings History.
When is Dynatronics' next earnings date?
What price target have analysts set for DYNT?
3 analysts have issued 1-year target prices for Dynatronics' shares. Their forecasts range from $3.75 to $4.00. On average, they expect Dynatronics' share price to reach $3.8750 in the next twelve months. This suggests a possible upside of 205.1% from the stock's current price. View Analyst Price Targets for Dynatronics.
What is the consensus analysts' recommendation for Dynatronics?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dynatronics.
What are Wall Street analysts saying about Dynatronics stock?
Here are some recent quotes from research analysts about Dynatronics stock:
- 1. According to Zacks Investment Research, "DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. " (7/16/2019)
- 2. Maxim Group analysts commented, "We recommend buying DYNT, a leading manufacturer and distributor of orthopedic soft goods, medical supplies, and physical therapy (PT) and rehabilitation (rehab) products, due to the opportunity to grow market share via acquisitions in the highly fragmented PT and rehab market. In support of this strategy, the company acquired Hausmann, a leading manufacturer of PT and athletic training equipment, in Bird & Cronin, a leading designer and manufacturer of orthopedic soft goods and specialty patient care products, in October 2017. We estimate that combined, Hausmann and Bird & Cronin account for roughly 60% of total revenue, and we expect them to benefit from key demographic trends, such as an aging US population." (4/4/2019)
Has Dynatronics been receiving favorable news coverage?
Media headlines about DYNT stock have been trending positive recently, according to InfoTrie. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Dynatronics earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the stock's share price in the next several days. View News Stories for Dynatronics.
Who are some of Dynatronics' key competitors?
Some companies that are related to Dynatronics include Nephros (NEPHD), Titan Medical (TMDI), T2 Biosystems (TTOO), PAVmed (PAVM), Nuvectra (NVTR), Interpace Diagnostics Group (IDXG), Restoration Robotics (HAIR), SANUWAVE Health (SNWV), RA Medical Systems (RMED), Neovasc (NVCN), Co-Diagnostics (CODX), Atossa Genetics (ATOS), DarioHealth (DRIO), Hancock Jaffe Laboratories (HJLI) and Biostage (BSTG).
What other stocks do shareholders of Dynatronics own?
Who are Dynatronics' key executives?
Dynatronics' management team includes the folowing people:
- Dr. Christopher Richard Von Jako, CEO & Director (Age 49)
- Mr. David A. Wirthlin, CFO & Sec. (Age 58)
- Mr. Terry M. Atkinson CPA, CGMA, Director of Accounting (Age 66)
- Mr. Daryl Connell, Chief Information Officer (Age 47)
- Mr. Skyler Black, Corp. Controller (Age 36)
Who are Dynatronics' major shareholders?
Dynatronics' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (0.60%) and Citadel Advisors LLC (0.36%). Company insiders that own Dynatronics stock include Brian Larkin, David Alma Wirthlin, Nancy Cronin, Stuart Essig, Thomas J Gephart and Ventures 1 Lp Provco. View Institutional Ownership Trends for Dynatronics.
Which institutional investors are buying Dynatronics stock?
DYNT stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc. and Citadel Advisors LLC. Company insiders that have bought Dynatronics stock in the last two years include Brian Larkin, David Alma Wirthlin, Stuart Essig, Thomas J Gephart and Ventures 1 Lp Provco. View Insider Buying and Selling for Dynatronics.
How do I buy shares of Dynatronics?
Shares of DYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Dynatronics' stock price today?
One share of DYNT stock can currently be purchased for approximately $1.27.
How big of a company is Dynatronics?
Dynatronics has a market capitalization of $10.69 million and generates $64.42 million in revenue each year. The medical equipment provider earns $-1,600,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis. Dynatronics employs 323 workers across the globe.View Additional Information About Dynatronics.
What is Dynatronics' official website?
How can I contact Dynatronics?
Dynatronics' mailing address is 7030 PARK CENTRE DRIVE, SALT LAKE CITY UT, 84121. The medical equipment provider can be reached via phone at 801-568-7000.
MarketBeat Community Rating for Dynatronics (NASDAQ DYNT)
MarketBeat's community ratings are surveys of what our community members think about Dynatronics and other stocks. Vote "Outperform" if you believe DYNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DYNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
